Presentations

MN-166 (ibudilast) Presentations

MN-166 (ibudilast) Presentations

MN-166 (ibudilast) for Progressive MS: American Academy of Neurology (AAN) Poster (0.5 MB)

MN-166 (ibudilast) for ALS: American Academy of Neurology (AAN) Poster (3.5 MB)

MN-166 (ibudilast) for Glioblastoma: American Society of Clinical Oncology (ASCO) Poster (10 MB)

MN-166 (ibudilast) for Opioid Dependence: American Academy of Neurology (AAN) Poster (0.4 MB)

MN-166 (ibudilast) for Methamphetamine Dependence: College on Problems of Drug Dependence (CPDD) Poster (0.4 MB)

MN-166 (ibudilast) for Alcohol Dependence: American College of Neuropsychopharmacology (ACNP) Poster (0.7 MB)

MN-166 (ibudilast) Publications

Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R; MN166-001 Investigators.
Neurology. 2010 Mar 30;74(13):1033-40. doi: 10.1212/WNL.0b013e3181d7d651. Epub 2010 Mar 3.
PMID: 20200338

Primary neuroprotection: the Holy Grail of multiple sclerosis therapy.
Fox RJ.
Neurology. 2010 Mar 30;74(13):1018-9. doi: 10.1212/WNL.0b013e3181d6b165. Epub 2010 Mar 3. No abstract available.
PMID: 20200341

Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia.
Mizuno T, Kurotani T, Komatsu Y, Kawanokuchi J, Kato H, Mitsuma N, Suzumura A.
Neuropharmacology. 2004 Mar;46(3):404-11.
PMID: 14975696

Ibudilast protects against neuronal damage induced by glutamate in cultured hippocampal neurons.
Tominaga Y, Nakamura Y, Tsuji K, Shibata T, Kataoka K.
Clin Exp Pharmacol Physiol. 1996 Jun-Jul;23(6-7):519-23.
PMID: 8800577

Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS.
Suzumura A, Ito A, Yoshikawa M, Sawada M.
Brain Res. 1999 Aug 7;837(1-2):203-12.
PMID: 10434004

Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development.
Suzumura A, Ito A, Mizuno T.
Mult Scler. 2003 Dec;9(6):574-8.
PMID: 14664469

Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity.
Yoshioka A, Shimizu Y, Hirose G, Kitasato H, Pleasure D.
J Neurochem. 1998 Jun;70(6):2416-23.
PMID: 9603206